Chi­na's mar­ket reg­u­la­tor fines, con­fis­cates rev­enue from phar­mas for mo­nop­o­liz­ing APIs for ep­i­neph­rine

3 years ago
R&D
China

Clar­i­ty want­ed: When can new drug price ne­go­ti­a­tions be chal­lenged in court?

3 years ago
Pharma
Law

Emer­gent to de­liv­er a $120M con­tract for the small­pox vac­cine for the US stock­pile

3 years ago
Pharma
Manufacturing

Mar­ket­ingRx roundup: Bio­gen be­gins so­cial aware­ness around post­par­tum de­pres­sion; Phar­ma mar­keters in the NBA games

3 years ago
Pharma
Marketing

Vi­a­tris re-ups med­ical ed­u­ca­tion spon­sor­ship pledge, adds health eq­ui­ty to pri­ma­ry care train­ing

3 years ago
Pharma
Marketing

Ake­bia to re­file ane­mia drug vadadu­s­tat af­ter FDA de­nied ap­peal

3 years ago
R&D

C4 Ther­a­peu­tics gets $35M from Bet­ta Phar­ma­ceu­ti­cals to de­vel­op and mar­ket NSCLC drug in Chi­na

3 years ago
Deals
R&D

Pfiz­er’s once-a-week he­mo­phil­ia an­ti­body re­duces bleed­ing in PhI­II study

3 years ago
R&D

XtalPi inks $250M pact with Lil­ly af­ter Pfiz­er suc­cess

3 years ago
Deals
China

Af­ter PhI­II let­down, Rain On­col­o­gy lays off 65% of staff, al­ters clin­i­cal plans for sole as­set

3 years ago
People
R&D

EU com­mit­tee like­ly to rec­om­mend against ap­prov­ing Amy­lyx ALS drug, com­pa­ny says

3 years ago
R&D
Pharma

Ve­rastem touts mid-stage da­ta in rare type of ovar­i­an can­cer: #AS­CO23

3 years ago
R&D

Atea's board re­jects un­so­licit­ed cash of­fer from Tang Cap­i­tal's Con­cen­tra

3 years ago
People
Deals

On­copep­tides says Swedish au­thor­i­ties end­ed probe in­to CSO Jakob Lind­berg over al­leged in­sid­er in­for­ma­tion shar­ing

3 years ago
People
Law

With cash run­ning low, Swedish cell ther­a­py com­pa­ny looks to sell off plat­form

3 years ago
R&D
Cell/Gene Tx

End­points 20(+2) un­der 40, 2023; Bio­phar­ma's high­est-paid CEOs; N-of-1 CRISPR sto­ry goes on af­ter tragedy; and more

3 years ago
Weekly

FDA ap­proves Lex­i­con’s heart-fail­ure drug af­ter de­feat in di­a­betes

3 years ago
Pharma
FDA+

Astel­las, Seagen add fire­fight­er mes­sag­ing in blad­der can­cer aware­ness cam­paign

3 years ago
Pharma
Marketing

Genen­tech spon­sors fash­ion-for­ward mod­els walk­ing and rolling the run­way again in SMA en­core show

3 years ago
Pharma
Marketing

Eu­ro­pean Com­mis­sion to re­ceive few­er Pfiz­er-BioN­Tech vac­cine dos­es un­der amend­ed con­tract

3 years ago
Pharma
Coronavirus

Evax­ion teas­es 67% re­sponse rate in PhI metasta­t­ic melanoma tri­al

3 years ago
R&D

Cor­rect­ed: Bench­Sci rais­es $70M Se­ries D for drug dis­cov­ery soft­ware; Zen­tal­is touts PhIb ovar­i­an can­cer da­ta

3 years ago
News Briefing

Take­da wins pri­or­i­ty re­view for $400M col­orec­tal can­cer drug, li­censed from Hutchmed in Jan­u­ary

3 years ago
R&D
FDA+

Arti­va boasts ear­ly NK cell ther­a­py re­sults, giv­ing life­line to part­ner Af­fimed

3 years ago
R&D
First page Previous page 335336337338339340341 Next page Last page
A service from the Financial Times